뒤로
Panacos Pharmaceuticals Inc(PANC) 가격
PANC 주가 차트
PANC 수입
Panacos Pharmaceuticals Inc
$0
0%
$0
종가: Feb 06, 16:00:00 GMT-5
$0
0%
$0
애프터마켓: Feb 06, 20:00:00 GMT-5
아직 데이터 없음Earnings FAQ
PANC의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Panacos Pharmaceuticals Inc PANC의 지난 분기 매출 실적은 어땠나요?
Panacos Pharmaceuticals Inc의 매출 추정치는 얼마인가요?
Panacos Pharmaceuticals Inc의 수익 품질 점수는 얼마인가요?
Panacos Pharmaceuticals Inc는 언제 수익을 보고하나요?
Panacos Pharmaceuticals Inc의 예상 수익은 얼마인가요?
Panacos Pharmaceuticals Inc은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$0.0001
시가
$0
일일 범위
$0 - $0.0001
52주 범위
$0 - $0.0001
거래량
200
평균 거래량
0
EPS(TTM)
-0.67
배당수익률
--
시가총액
$5.3K
PANC란 무엇인가요?
Panacos Pharmaceuticals, Inc. engages in the discovery and development of small-molecule oral drug which is designed to treat human immunodeficiency virus and other major human viral diseases. The company is headquartered in Watertown, Massachusetts and currently employs 41 full-time employees. The firm's lead product candidate, bevirimat, is an oral HIV drug candidate in Phase II clinical testing. Panacos has dosed over 485 patients and subjects with bevirimat and have seen a good safety and tolerability profile with no indication of a relationship between adverse events and drug levels. The firm has exclusive rights from University of North Carolina at Chapel Hill (UNC) to the United States patent claiming the chemical entity bevirimat. Panacos has an exclusive worldwide license with UNC for all indications.